Form 4 for IDXX Idexx Laboratories
Accepted 2024-09-04 00:00:00 ET · period of report 2024-09-01 · accession 0000874716-24-000127 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-09-04 | 2024-09-01 | IDXX | Schreck Michael | EVP | M - OptEx | $0.00 | +164 | 961 | +21% | $0 |
| D | 2024-09-04 | 2024-09-01 | IDXX | Schreck Michael | EVP | F - Tax | $481.33 | -48 | 913 | -5% | -$23.1K |
| D | 2024-09-04 | 2024-09-01 | IDXX | Schreck Michael | EVP | M - OptEx | — | -164 | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-01 | M | A | 164 | $0.00 | 961 | D | — | — | (F1) Includes 11 shares purchased under the Issuer's Employee Stock Purchase Plan June 28, 2024. |
| 2 | Common | Common Stock | 2024-09-01 | F | D | 48 | $481.33 | 913 | D | — | — | (F2) Closing price of Issuer common stock on August 30, 2024. |
| 3 | Derivative | Restricted Stock Unit | 2024-09-01 | M | D | 164 | — | 0 | D | — · — to — | 164 Common Stock | (F4) Not applicable. (F3) Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in four annual installments beginning on September 1, 2021. |